Claims for Patent: 9,931,458

Summary for Patent: 9,931,458

Title:	Multi chamber flexible bag and methods of using same
Abstract:	A method of preparing a pharmaceutical product in a single multiple chamber flexible bag. A pharmaceutical product is introduced in a liquid state into a first chamber of the flexible bag through a first port. The pharmaceutical product is lyophilized within the first chamber of the flexible bag to provide a lyophilized pharmaceutical product. The flexible bag has a second chamber and the first chamber and the second chamber are separated by a breakable seal. The second chamber further includes a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber. A user may apply pressure to the flexible bag to break the seal and mix the lyophilized pharmaceutical product and the reconstituting solution to order to administer the pharmaceutical product to a patient.
Inventor(s):	Di Naro; Antonio Francesco (Morcote, CH)
Assignee:	ADIENNE PHARMA & BIOTECH SA (Lugano, CH)
Application Number:	15/667,785
Patent Claims:	1. A flexible pharmaceutical bag comprising: a first chamber configured to hold a lyophilized pharmaceutical product; a second chamber separated from the first chamber, the second chamber configured to hold a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber; a seal disposed between the first chamber and the second chamber that separates and seals the first chamber from the second chamber; and a first port attached to the first chamber, the first port configured to introduce a pharmaceutical product into the first chamber and allow passage of water vapor from the pharmaceutical product during lyophilization of the pharmaceutical product. 2. The pharmaceutical bag of claim 1, further comprising a second port attached to the second chamber, the second port configured to introduce the reconstituting solution to the second chamber for reconstituting the lyophilized pharmaceutical product in the first chamber. 3. The pharmaceutical bag of claim 1, wherein the seal is a connection between a front surface of the pharmaceutical bag and a back surface of the pharmaceutical bag. 4. The pharmaceutical bag according to claim 1, wherein the seal extends the length of the pharmaceutical bag between the first chamber and the second chamber. 5. The pharmaceutical bag according to claim 1, wherein a predetermined amount of pressure applied to the pharmaceutical bag breaks the seal and connects the second chamber to the first chamber. 6. The pharmaceutical bag according to claim 1, wherein the seal further comprises a weak point to provide an initial breaking point when a predetermined amount of pressure is applied to the pharmaceutical bag. 7. The pharmaceutical bag according to claim 1, wherein the pharmaceutical product is an antineoplastic, an immunomodulating agent, or a cytotoxic drug. 8. The pharmaceutical bag according to claim 1, wherein the pharmaceutical product is selected from the group consisting of: azacytidine, belinostat, bendamustine, brentuximab vedotin, bleomycin, bortezomib, busulfan, carboplatin, cyclophosphamide, cytarabine, dacarbazine, dactinomycin, daunorubicin, decitabine, deferoxamine, doxorubicin, epirubicin hydrochloride, fludarabine, fotemustine, fulvestrant, gemcitabine, idarubicin, ifosfamide, irinotecan hydrochloride, ixabepilone, melphalan, methotrexate, oxaliplatin, paclitaxel, pemetrexed, pentostatin, raltitrexed, romidepsin, temozolomide, thiotepa, topotecan, trabectedin, trastuzumab, and vinblastine. 9. The pharmaceutical bag according to claim 1, wherein the reconstituting solution is a 0.9% saline solution. 10. The pharmaceutical bag according to claim 1, wherein the pharmaceutical bag is fabricated from a polyolefine/styrene-block copolymer based film. 11. The pharmaceutical bag according to claim 1, wherein the pharmaceutical bag withstands 121.degree. Celsius. 12. The pharmaceutical bag according to claim 1, wherein the pharmaceutical bag withstands -45.degree. Celsius. 13. The pharmaceutical bag according to claim 1, wherein the second chamber further comprises an administration port for administering a reconstituted pharmaceutical product that is a result of mixing the lyophilized pharmaceutical product and the reconstituting solution. 14. A flexible pharmaceutical bag comprising: a front film; a back film; an outer seal joining the front film to the back film around a perimeter of the pharmaceutical bag; and a breakable seal joining the front film and the back film interior of the outer seal, the breakable seal defining a first chamber and a second chamber separated from the first chamber, wherein the first chamber is configured to hold a lyophilized pharmaceutical product, wherein the second chamber is configured to hold a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber, and wherein the breakable seal breaks before the outer seal when a predetermined amount of pressure is applied to the flexible pharmaceutical bag. 15. The flexible pharmaceutical bag according to claim 14, wherein the first chamber and the second chamber are defined by the outer seal and the breakable seal.

Details for Patent 9,931,458

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	09/25/1998		2037-05-31
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	02/10/2017		2037-05-31
Seagen Inc.	ADCETRIS	brentuximab vedotin	For Injection	125388	08/19/2011		2037-05-31
Genentech, Inc.	HERCEPTIN HYLECTA	trastuzumab and hyaluronidase-oysk	Injection	761106	02/28/2019		2037-05-31